| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |